Signal strength of AEs of TAF at the System Organ Class (SOC) level in FDA Adverse Event Reporting System (FAERS) source.

<p>Signal strength of AEs of TAF at the System Organ Class (SOC) level in FDA Adverse Event Reporting System (FAERS) source.</p>

Saved in:

Bibliographic Details
Main Author:	Chao Zhang (51048) (author)
Other Authors:	Jiaqi Wen (6838376) (author), Yinghui Li (237776) (author)
Published:	2025
Subjects:	Medicine Pharmacology Biotechnology Cancer Mental Health Infectious Diseases Virology world disproportionality analysis reporting odds ratio hepatitis b virus enhance patient adherence 57692002 case reports management protocols especially adverse events associated 1911 reported taf term tenofovir alafenamide mitigate resistance risks faers )</ p term management tenofovir alafenamide adverse events related risks xlink "> worth noting uneven distribution thereby necessitating swallowing difficulties safety characteristics research objective providing support prioritize strengthening practical settings poisson shrinker neurological symptoms marketing evidence marked increase major suspected lipid profiles healthcare providers faers database etc ., drug resistance drug administration database maintained clinical vigilance cerebral infarction bone pain benefit balance bcpnn ), analyzing data aes ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items